-

VisualDx Announces Collaboration with Janssen to Pilot New API and Bring Equitable AI to the Point of Care

Clinical Decision Support Pioneer to Integrate Leading Diagnostic AI with External Applications

ROCHESTER, N.Y.--(BUSINESS WIRE)--VisualDx, a global leader in web-based clinical decision support (CDS), today announced that it has entered into an agreement with Janssen Biotech, Inc., one of the pharmaceutical companies of Johnson & Johnson. Through this collaboration, the Research & Development data science team at Janssen will leverage the VisualDx application programming interface (API) as a beta partner and the new interface will enable provider organizations and other healthcare technology companies to bring VisualDx’s industry-defining CDS into third-party applications to enhance diagnostic accuracy and improve health outcomes, particularly for traditionally marginalized patient populations. This agreement was facilitated by Johnson & Johnson Innovation.

For more than 20 years, VisualDx has focused on building solutions that reduce racial and other forms of bias in the clinical decision-making process. As a result, VisualDx maintains hundreds of thousands of professional diagnostic medical images in its collection, with more than one-third of those images in pigmented skin. The VisualDx API will enable end users to assess skin disorders from images, assisted by VisualDx’s AI, which is scientifically proven to analyze from light to dark skin images, with the same degree of accuracy.

“The medical community is finally reckoning with its history of racism and underrepresentation of people of color in clinical training,” said Dr. Art Papier, CEO and co-founder at VisualDx. “VisualDx technology can help reverse that narrative by bringing expertise on skin of color to providers of all specialties. We’re thrilled to have a global leader in medicine help us in our efforts to validate our API, be a strategic partner in research and to place our platform into the hands of even more clinicians for the benefit of patients around the world.”

About VisualDx

VisualDx is an award-winning diagnostic clinical decision support system that has become the standard medical professional resource at more than 50% of U.S. medical schools and more than 2,300 hospitals and clinics worldwide. VisualDx combines problem oriented clinical search with the world's best curated medical image library, plus medical knowledge from experts and sophisticated machine learning algorithms to help with differential diagnosis, variation, treatment, and patient communication. Our mission is to improve healthcare decision making and reduce diagnostic errors. Learn more at www.visualdx.com.

Contacts

Media Contact:
Jennifer Brooks
Aria Marketing for VisualDx
479.426.6855
jbrooks@ariamarketing.com

VisualDx


Release Summary
VisualDx has announced a new collaboration with Janssen Biotech, Inc., in which Janssen will leverage VisualDx’s API to improve diagnostic accuracy.
Release Versions

Contacts

Media Contact:
Jennifer Brooks
Aria Marketing for VisualDx
479.426.6855
jbrooks@ariamarketing.com

More News From VisualDx

VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions

ROCHESTER, N.Y.--(BUSINESS WIRE)--VisualDx, an award-winning web-based clinical decision support system, has received a grant from the Bill & Melinda Gates Foundation to develop diagnostic and surveillance tools to help medical providers improve treatment decisions and outcomes in underserved areas. VisualDx will expand equitable access to its clinical decision support, artificial intelligence (AI) and machine learning (ML) tools to provide guidance, specialist knowledge, and education for...

Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response

BURLINGTON, Vt.--(BUSINESS WIRE)--The Vermont Department of Health has launched a first-of-a-kind program to support healthcare professionals with timely information on disease diagnosis, testing, treatment and patient education resources — improving public health response statewide. The Clinician Support Initiative provides access to a vast collection of images and clinical information about public health threats, including hMPXV (human monkeypox virus), COVID-19 and Lyme disease. Available on...

VisualDx Partners with American College of Emergency Physicians to Build Library of Monkeypox Images

ROCHESTER, N.Y.--(BUSINESS WIRE)--Ahead of the American College of Emergency Physicians (ACEP) Scientific Assembly (October 1-4), VisualDx today announced a collaboration with ACEP to create the Monkeypox Emergency Medicine Project, a physician-sourced collection of monkeypox images. By offering access to images of varying disease presentations on real patients, VisualDx and ACEP are helping to further educate and prepare emergency physicians to test, diagnose, and treat the emergent disease. A...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.